medigraphic.com
SPANISH

Atención Familiar

ISSN 1405-8871 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 3

Next >>

Aten Fam 2022; 29 (3)

Challenges of Long covid in Primary Health Care in Mexico

López-Ortiz E
Full text How to cite this article

Language: Spanish
References: 13
Page: 133-134
PDF size: 102.16 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Thompson J, Wattam S. Estimating the impact ofinterventions against COVID-19: From lockdownto vaccination. PLoS One. 2021;16(12):e0261330.DOI: 10.1371/journal.pone.0261330.

  2. OECD. Priority setting and coordination of researchagendas: lessons learned from COVID-19[Internet]. [Citado 2022 May 11]. Disponible en:https://www.oecd.org/sti/inno/priority-settingand-coordination-of-research.htm

  3. Kenny G, McCann K, O’Brien C, Savinelli S,Tinago W, Yousif O, et al. Identification of DistinctLong COVID Clinical Phenotypes ThroughCluster Analysis of Self-Reported Symptoms.Open Forum Infect Dis. 2022;9(4):ofac060. DOI:10.1093/ofid/ofac060.

  4. Spudich S, Nath A. Nervous system consequencesof COVID-19. Science. 2022;375(6578):267-269. DOI: 10.1126/science.abm205.

  5. Knight JS, Caricchio R, Casanova JL, CombesAJ, Diamond B, Fox SE, et al. The intersectionof COVID-19 and autoimmunity. J Clin Invest.2021;131(24):e154886. DOI: 10.1172/JCI154886.

  6. Metwally AA, Mehta P, Johnson BS, NagarjunaA, Snyder MP. COVID-19-Induced New-OnsetDiabetes: Trends and Technologies. Diabetes.2021;70(12):2733-44. DOI: 10.2337/dbi21-0029.

  7. Brodin P, Casari G, Townsend L, O’Farrelly C,Tancevski I, Löffler-Ragg J, et al. Studying severelong COVID to understand post-infectious disordersbeyond COVID-19. Nat Med. 2022;28:879-

  8. DOI: 10.1038/s41591-022-01766-7.8. Venkatesan P. NICE guideline on long COVID.Lancet Respir Med. 2021;9(2):129. DOI:10.1016/S2213-2600(21)00031-X.

  9. Sisó-Almirall A, Brito-Zerón P, Ferrín LC, KostovB, Moreno AM, Mestres J, et al. Long covid-19:Proposed primary care clinical guidelines for diagnosisand disease management. Int J Environ ResPublic Health. 2021;18(8):4350. DOI: 10.3390/ijerph18084350.

  10. Baraniuk C. Covid-19: How Europe is approachinglong covid. BMJ. 2022;376:o158. DOI:10.1136/bmj.o158.

  11. Walter K. An Inside Look at a Post-COVID-19Clinic. JAMA. 2021;325(20):2036-2037. DOI:10.1001/jama.2021.2426.

  12. Bazdyrev E, Rusina P, Panova M, Novikov F,Grishagin I, Nebolsin V. Lung Fibrosis afterCOVID-19: Treatment Prospects. Pharmaceuticals(Basel). 2021;14(8):807. DOI: 10.3390/ph14080807.

  13. ClinicalTrials.Gov. Search of: long covid - List Results- ClinicalTrials.gov [Internet]. [Citado 2022May 11]. Disponible en: https://clinicaltrials.gov/ct2/results?cond=long+covid&term=&cntry=&state=&city=&dist=




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Aten Fam. 2022;29